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license (http://creativecommons.org/Abstract Introduction: The vast majority of cardiac implantable electronic device (CIED) re-
cipients require transvenous lead insertion, which may be hindered by the presence of venous
anomalies. The aim of this study was to determine the prevalence and variations of persistent
left superior vena cava (PLSVC) and to conduct subsequent outpatient follow-up in terms of
device function and the clinical condition of the recipients using data from CIED placement
procedures conducted over a 12-year period.
Methods: The study population included patients undergoing first-time transvenous implanta-
tion of cardiac pacemakers and implantable cardioverter-defibrillators (ICDs). The presence of
PLSVC was determined based on intra-procedure venography. Outpatient follow-up involved
assessments of patient condition, radiological imaging, and CIED function.
Results: Of a total of 4708 CIED recipients, PLSVC was detected in eight patients (mean age
65.5 13.9); five of them had double superior vena cava (DSVC), including three cases in which
the vessels were bridged with a brachiocephalic vein (BCV). Three patients presented PLSVC
associated with the absence of the right superior vena cava (RSVC), a very rare anomaly. Seven
patients remain under observation, for a total of 78.4 48.4 months of follow-up.
Conclusions: The rate of venous anomalies in the form of PLSVC detected in the evaluated pop-
ulation was 0.17%. These PLSVC cases were asymptomatic, which hindered their earlierk, MD, PhD, Department of Cardiology and Arterial Hypertension, Central Research Hospital, the
tr., 02-507 Warsaw, Poland. Tel.: þ48 22 508 16 70; fax: þ48 22 508 16 80.
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102 R. Steckiewicz et al.detection. The presence of these anomalies made the procedures more challenging for the
operator and increased the perioperative complication rates; however, neither patient condi-
tion nor CIED function was affected based on the long-term outpatient follow-up.
ª 2016 Hellenic Cardiological Society. Publishing services by Elsevier B.V. This is an open ac-
cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Currently, the most common permanent cardiac pacing
technique involves transvenous placement of cardiac
pacemakers and implantable cardioverter-defibrillators
(ICDs). Cardiac lead insertion is determined by both
patency and favourable layout of the venous vascular
system from the lead insertion site to final lead placement
within the heart.1,2 Intra-procedure detection of venous
system variations that deviate from their typical
anatomical layout may sometimes significantly affect the
course of the procedure.3e6 Unless such systemic vein
anomalies co-occur with other clinically apparent
congenital heart defects,7 they typically remain unde-
tected until certain cardiological and anaesthesiological
procedures or diagnostic assessments are conducted for
other reasons.8e12
The venous anomalies discussed here were diagnosed
based on intra-procedure contrast-enhanced imaging
revealing the presence of persistent left superior vena
cava (PLSVC). Intra-procedure venography still remains
the “golden standard” in venous diagnostics because it
helps visualize vascular layout and morphology and
helps determine the nature of the anomaly, which fa-
cilitates the selection of the optimal route of cardiac
lead placement within the chambers of the right
heart.13 The goal of this study was to determine the
prevalence and variants of PLSVC in cardiac electronic
implantable device (CIED) recipients. The follow-up was
conducted in an outpatient setting over a 12-year
period and focused on the direct effects of the pres-
ence of PLSVC on the course of the procedure as well
as on CIED function.
2. Methods
A total of 4708 CIED (i.e., cardiac pacemaker and ICD) re-
cipients who underwent transvenous implantation between
January 1, 2003, and December 31, 2014, were included in
the study.
CIEDs were implanted in the infraclavicular region, and
cardiac leads were inserted either via the cephalic vein
(CV) cutdown and/or axillary vein (AV)/subclavian vein (SV)
puncture approach. The cause of lead insertion difficulties
and/or unusual lead position was investigated using
contrast administration into the CV or directly into the AV
or SV. Intra-procedure measurements of pacing parame-
ters, such as action potential amplitude, stimulation
threshold at a pulse duration of 0.5 msec and pacing
impedance, were taken with device-specific readers. Post-procedure follow-up was continued in an outpatient setting
and included periodic assessment of device function,
location, and immediate surroundings, as well as the pa-
tient’s clinical status.
3. Results
During the evaluated period, CIEDs were implanted trans-
venously in 4708 patients, 52% of which were female. In 97%
of cases, the procedure was conducted via venous access
from the left infraclavicular region. PLSVC was revealed in
eight patients, including five women and three men, which
constituted 0.17% of the study population (Table 1).
The PLSVC patient group included three different
morpho-anatomical subtypes of this venous anomaly:
e three patients (cases number 1, 4, and 7) were diag-
nosed with double superior vena cava (DSVC) with a
developed patent left brachiocephalic vein (LBCV) bridge
connecting both vessels (Fig. 1)
e two patients (cases number 2 and 3) had DSVC without
a brachiocephalic vein (BCV) bridge (Fig. 2)
!e three patients (see case reports 5, 6, and 8) had a single
superior vena cava (SSVC), which is a PLSVC in the absence
(agenesis) of the right superior vena cava (RSVC) (Fig. 3).
All of these PLSVC patients eventually received three
single-chamber cardiac pacing systems, including one atrial
(AAI type device e case 1) due to sinus node dysfunction
and two ventricular (VVI type devices e cases 3, 6, and 7)
due to third-degree (complete) atrioventricular block with
sinus rhythm and chronic atrial fibrillation; in addition, four
dual-chamber pacemakers (DDD type) were implanted due
to tachycardia-bradycardia syndrome (cases 2 and 4) or
complete atrioventricular block with sinus rhythm (cases
5). One patient (case 8) received an ICD-VR for the sec-
ondary prevention of ventricular tachycardia.
Venography conducted in three patients (cases 1, 4, and
7) because of an unusual course of the procedures (leads
inserted through the PLSVC and the coronary sinus into the
right atrium were unintentionally introduced into the RSVC)
revealed the presence of DSVC with BCV, with contrast
administration showing the precise layout of these vessels.
In two patients (cases 2 and 3), the presence of DSVC
without BCV was confirmed, independent of intra-
procedure venography, via computed tomography angiog-
raphy (CTA). A previous CTA performed in one patient (case
8) provided information about the presence and the type of
LSVC prior to the procedure, which was confirmed via intra-
procedure venography. In two patients (cases 5 and 6), lead
position during lead introduction suggested the presence of
PLSVC, and intra-procedure venography showed a lack of
Table 1 CIED implantation procedures in patients with PLSVC.
Sex (F/M),
age (years)
Venous
anomaly
Indication for
CIED implantation
Year of implantation,
implanted device
type and model
Lead model Venous
access
Case 1
(Fig. 1)
M, 41 DSVC with a
BCV bridge
symptomatic sick
sinus syndrome
2003, AAI,
Biotronik Axios SR
Biotronik SX-53-JBP /t/ left CV
cutdown
2006, AAI, reimplantation
due to lead damage -
Vitatron C20SR
Vitatron ICF09B /s/ left AV
puncture
Case 2
(Fig. 2)
F, 77 DSVC without
BCV bridge
TBS (PAF / PSVTþ
sinus bradycardia)
2006, DDD, Medtronic
Sigma SD303
Medtronic:
A e 5592-53 /t/
V e5092-58 /t/
left AV
puncture
Case 3 F, 80 DSVC without
BCV bridge
complete AV block 2006, VVI,
Medtronic Sigma
SR 303
Medtronic 5092 -58 /t/ left AV
puncture
Case 4 M, 61 DSVC with a
BCV bridge
TBS (PAFþ sinus arrest
with escape nodal
rhythm)
2007, DDD,
St. Jude Medical
Verity DR
St. Jude Medical:
A-Tendril SDX-52 /s/
V-Tendril SDX-58 /s/
left AV
puncture
Case 5 F, 52 PLSVC without
RSVC
complete AV block in
course of Wegener’s
granulomatosis
VI.2009, VVI, Biotronik
Talos SR
Biotronik Selox ST /t/ right AV
puncture
VII.2009,
Biotronik Talos DR
Vitatron:
A-Crystalline 52 /s/
V-Crystalline 58 /s/
Case 6
(Fig. 3)
F, 67 PLSVC without
RSVC
sustained AF with
complete AV block
2013, VVI,
Biotronik Ecuro SR-T
Biotronik Setrox S-60 /s/ left AV
puncture
Case 7 F, 80 DSVC with a
BCV bridge
sustained AF with
AV block
2004, VVI,
Medtronic Sigma SS203
Medtronic 5092-58 /t/ left AV
puncture
2014, VVI,
Medtronic Sensia SR
St. Jude Medical
Tendril STS 58 /s/
Case 8 F, 66 PLSVC without
RSVC
Turner syndrome with
LQTS and torsade
des pointes
2014, ICD-VR,
Medtronic Cardia VR
Medtronic 6935-65 /s/ left AV
puncture
F e female; M e male; CIED e cardiac implantable electronic device; DSVC e double superior vena cava; BCV e brachiocephalic vein;
PLSVC e persistent left superior vena cava; RSVC e right superior vena cava; TBS e tachycardia-bradycardia syndrome; PAF e parox-
ysmal atrial fibrillation; PSVT e paroxysmal supraventricular tachycardia; AV e atrio-ventricular; AF e atrial fibrillation; LQTS e long-QT
syndrome; lead model: A e atrial; V e ventricular; lead tip: s e screw-in; t e tined; CV e cephalic vein; AV e axillary vein
Figure 1 (A, B, C, D). Case 1. (A) Chest X-ray, posterior-anterior (PA) view, showing the atrial lead implanted in September 2003;
(B) Venography showing contrast flow through both SVCs and the BCV connecting them (2003); (C, D) An X-ray film (January 2013)
also showing the new lead implanted in May 2006, in (C) PA and (D) lateral views.
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Figure 2 (A, B, C, D). Case 2. Intra-procedure fluoroscopy (Feb. 2006): contrast administration revealed LSVC without BCV. (A)
Lead manipulation showed the presence of RSVC. (B) Chest X-ray from hospitalization for pneumonia (Jan. 2013). Massive opacities
in the right middle lung field with parietal pleura thickening, pronounced adhesions, evidence of pneumothorax around the right
lower lung field, and an air-fluid level in the right pleural cavity (C, D).
Figure 3 (A, B). Case 6. Radiographic image of lead position in PLSVC (arrow/, venography reveals a lack of RSVC) and the
position of the implanted 29-mm aortic Medtronic Core Valve in (A) posterior-anterior and (B) lateral views.
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diagnosed with PLSVC intra-procedurally at another centre.
Ineffective stimulation by a device implanted from the left-
side approach determined the need to repeat the proce-
dure, this time via venous access through the right SV and
BCV. Lead insertion into the cardiac chambers through the
RSVC was impossible as the CTA showed evidence of the
vessel’s agenesis. In all of the PLSVC cases, venous blood
collected by the coronary sinus (CS) drained into the right
atrium. None of these patients showed any evidence of a
congenital heart defect in post-procedure transthoracic
echocardiography.
Three patients developed complications requiring reop-
eration. Two patients had cardiac lead displacement in the
early postoperative period (in week 1 e case 2 and in week
2 e case 5); in both cases tined (passive-fixation) leads had
been used. However, in the third patient (case 1), the lead
was damaged as a result of trauma three years followingpacemaker implantation, which necessitated another lead
implantation. Following the required lead placement pro-
cedures, pacing parameters recorded during subsequent
scheduled outpatient visits showed consistently normal
stimulation thresholds, lead resistance, and impulse
amplitude, as in the other patients.
The procedures described in this paper were charac-
terized by a longer patient and staff X-ray exposure time,
ranging from 1.75 min to 40.2 min [mean standard devi-
ation (SD) 13.95 min 13.7 min], whereas X-ray exposure
duration in 100 similar procedures in patients without
venous anomalies varied from 0.12 min to 7.08 min
(0.98 1.1 minutes; p <0.005).
Total outpatient follow-up duration from the time of the
procedure until study follow-up completion (Dec. 31, 2014)
ranged from 2 to 134 months (78.4 48.4 months). None of
the patients developed symptoms suggesting ipsilateral
venous thrombosis.
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Venous vascular system development is characterized by a
much greater variety than that of arterial vessels. In
asymptomatic cases, a venous anomaly can be detected
only in favourable circumstances. For example, PLSVC can
be detected during transvenous implantation of a perma-
nent cardiac pacing device.1,8,14,15 The prevalence of
persistent left superior vena cava in the population is
approximately 0.3e0.5%, and the anomaly is usually found
incidentally during post-mortem examinations, invasive
cardiological procedures, cardio-thoracosurgical pro-
cedures or echocardiography.9,11,12,16 The prevalence of
this systemic vein anomaly in the evaluated patient popu-
lation was 0.17%, which was slightly lower than that re-
ported in the literature.
PLSVC draining into the left atrium, with the presence of
a left-right shunt is found sporadically, usually in associa-
tion with severe, symptomatic cardiovascular pathologies,
such as unroofed coronary sinus defect type 1.1,17,18
The prevalence of PLSVC is higher when the anomaly
coincides with congenital heart defects (3e10%), such as
ventricular septal defect (VSD), atrial septal defect (ASD),
pulmonary valve stenosis, common atrioventricular canal,
dextrocardia, and triatrial heart.5,11,19 In the cases
described here, transthoracic echocardiography assess-
ments showed no congenital heart defects. The observed
individual vascular variations resulting from embryological
development anomalies can be classified into three main
anatomical forms of PLSVC: DSVC either with (Fig. 1) or
without (Fig. 2) a connection via the innominate vein and a
single PLSVC (SLSVC) with an underdeveloped RSVC
(Fig. 3).8,20e23
A considerable majority of our patients underwent their
procedures via a left-sided infraclavicular approach. This
technique increases the likelihood of detecting a PLSVC-
like systemic venous anomaly and leads to a more accurate
estimate of its actual prevalence.
Patent DSVC can be found in approximately 85% of adults
with PLSVC. Our data showed that PLSVC was accompanied
by RSVC in 5 of 8 (62.5%) cases. However, the prevalence of
DSVC with a bridging BCV (cases 1, 4, and 7) seems to be
somewhat higher. This is most likely because this anomaly
remains undetected in patients in whom the angle of BCV
allows for lead insertion into RSVC, and it is only via
venography that this systemic vein anomaly can be detec-
ted (case 7).
The absence of vascular bridge formation between both
anterior cardinal veins (approximately 65%) leads to a lack
of the innominate vein; this rate is higher than that
observed in our study [two of five cases (33%)].7,12
!Developmental anomalies of the right common cardinal
vein that result in the absence of RSVC occur in 10e20% of
cases; the pertinent rate in our study being 37% (cases 5, 6,
and 8). This venous configuration is hemodynamically signif-
icant, as the blood draining from the upper part of the body
into the right atrium can flow only through PLSVC.7,8,12
The presence of PLSVC as well as its morphology
(confluence angles, valves) hinders lead manipulation and
placement in the right ventricle, as it requires negotiating
the acute angle between the orifice of the coronary sinusand the tricuspid valve.24 This manoeuvre may be facili-
tated by moulding the lead into a suitable shape, usually
resembling the Greek letter alpha (a).4,24
The procedures presented here were characterized by a
longer than usual patient and personnel exposure to X-rays.
This was a result of both the non-routine cardiac lead
insertion technique and the need for precise visualization
and radiographic documentation of the detected PLSVCs.8
The increased challenge of non-routine cardiac lead
insertion may also affect intra-procedure pacing parame-
ters and contribute to postoperative problems (cases 2, 3,
and 5).
The use of CTA either prior to or after the procedure
helps accurately locate and assess the layout of systemic
veins against the adjacent structures and sometimes helps
detect significant concomitant pathologies.25,26 CTA
allowed for the accurate diagnosis of a left lung tumour
detected during a CIED implantation procedure in one of
our patients (case 5). This case was later elaborated in a
separate report due to the rarity of atrioventricular con-
duction disturbances caused by Wegener’s
granulomatosis.27
The outpatient follow-up is ongoing in seven patients
with PLSVC, and the conducted assessments confirm normal
pacing parameters and lead placement. In January 2013,
after 84 months of follow-up, one patient died as a result of
cardiopulmonary failure associated with upper respiratory
tract inflammation.
The literature mostly contains reports of CIED implan-
tation in individual patients with PLSVC, only rarely
describing larger patient groups and addressing variations
.13e15,28 Our study presents eight patients with PLSVC who
received a CIED in a single centre during a 12-year period.
Three of these patients had DSVC with a bridging BCV, two
had DSVC without a venous bridge, and three had the rare
variation of PLSVC with absent RSVC. This article presents
morpho-anatomical variations of systemic vein anomalies
and is one of only a handful of manuscripts that include
postoperative follow-up.
5. Conclusions
The prevalence of PLSVC in our patients, 0.17%, was slightly
lower than that reported in the literature. The presented
PLSVC cases were asymptomatic, which hindered their
earlier diagnosis. Although the presence of PLSVC made the
implantation procedures more challenging, follow-up as-
sessments showed that this had no effect on the long-term
function of the implanted devices.References
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